IL26210A - Pharmaceutical compositions containing substituted sulphoxides - Google Patents

Pharmaceutical compositions containing substituted sulphoxides

Info

Publication number
IL26210A
IL26210A IL2621066A IL2621066A IL26210A IL 26210 A IL26210 A IL 26210A IL 2621066 A IL2621066 A IL 2621066A IL 2621066 A IL2621066 A IL 2621066A IL 26210 A IL26210 A IL 26210A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
containing substituted
sulphoxides
substituted sulphoxides
Prior art date
Application number
IL2621066A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL26210A publication Critical patent/IL26210A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL2621066A 1965-08-02 1966-07-25 Pharmaceutical compositions containing substituted sulphoxides IL26210A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47667665A 1965-08-02 1965-08-02

Publications (1)

Publication Number Publication Date
IL26210A true IL26210A (en) 1970-12-24

Family

ID=23892803

Family Applications (1)

Application Number Title Priority Date Filing Date
IL2621066A IL26210A (en) 1965-08-02 1966-07-25 Pharmaceutical compositions containing substituted sulphoxides

Country Status (5)

Country Link
BE (1) BE684960A (sv)
FR (2) FR5698M (sv)
GB (1) GB1125409A (sv)
IL (1) IL26210A (sv)
NL (1) NL6610878A (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984480A (en) * 1970-05-12 1976-10-05 L'oreal Polyhydroxyl monosulfoxide surfactant
LU86229A1 (fr) * 1985-12-27 1987-07-24 Oreal Compositions cosmetiques pour le traitement de la peau et des cheveux gras,a base de di(beta-hydroxyethyl)sulfoxyde,et leur application
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
DE60216305T2 (de) * 2001-10-03 2007-07-05 Celator Pharmaceuticals, Inc. Zusammensetzungen und Verfahren zur Abgabe von Arzneimittelkombinationen
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations

Also Published As

Publication number Publication date
FR5698M (sv) 1968-02-19
FR1505490A (fr) 1967-12-15
BE684960A (sv) 1967-02-02
GB1125409A (en) 1968-08-28
NL6610878A (sv) 1967-02-03

Similar Documents

Publication Publication Date Title
IL26726A (en) N-p-chlorobenzoyl-5-fluorocytosine and pharmaceutical composition containing it
IL26885A (en) Pharmaceutical silicone compositions
CY681A (en) Pharmaceutical compositions
IL26210A (en) Pharmaceutical compositions containing substituted sulphoxides
CY658A (en) Pharmaceutical compositions
IL26209A (en) Pharmaceutical compositions containing substituted sulphones
MY6900365A (en) Wood-treatment compositions
PH10499A (en) 2-amidopenicillins and pharmaceutical compositions containing them
IL33328A0 (en) Pharmaceutical compositions containing triazolo-pyrazine derivatives
IL33030A0 (en) 1-carbamoylpyrazole-4-sulfonamides and pharmaceutical compositions containing them
AU404794B2 (en) Pharmaceutical compositions containing benzyljulfoxides
IL26752A (en) Fungicidal compositions containing 1-guanidylanthraquinone derivatives
IL25499A (en) Ketoamines and compositions containing them
IL32179A0 (en) Ulcer-inhibitory pharmaceutical compositions
AU576466A (en) Pharmaceutical compositions containing benzyljulfoxides
IE29341L (en) Pharmaceutical composition
MY7200110A (en) Pharmaceutical compositions containing bisphenyl-alkenylamine derivatives
AU421611B2 (en) Pharmaceutical compositions
AU412250B2 (en) Pharmaceutical compositions
AU410622B2 (en) Pharmaceutical compositions
IE31952B1 (en) Pharmaceutical compositions
IE29406L (en) Cephalosporin containing compositions
IL22814A (en) Pharmaceutical composition containing 1alpha-phenylethylguanidine
IE29423L (en) 3 - iodo - 4 - hydroxy- 5 - nitrobenzonitrile derivatives;¹anthelmintic compositions
AU1165466A (en) Pharmaceutical compositions